While none of these proteins was found to be mutated in BRM-deficient cancer cell lines, HDAC9 and GATA3 were overexpressed in both lung cancer-derived cell lines and primary lung tumors, as well as in rhabdoid cell lines and primary tumors (21, 52). This evidence concerns the gene HDAC9 and cancer.